MiMedx Group, Inc.
MDXG
$7.22
$0.060.84%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.77% | 6.85% | 5.34% | 8.52% | 10.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.77% | 6.85% | 5.34% | 8.52% | 10.93% |
| Cost of Revenue | 24.31% | 19.47% | 15.29% | 9.96% | 3.34% |
| Gross Profit | 12.87% | 4.34% | 3.37% | 8.23% | 12.58% |
| SG&A Expenses | 20.95% | 14.78% | 2.36% | 0.04% | -2.09% |
| Depreciation & Amortization | -33.94% | -23.26% | -11.55% | 0.13% | 1.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.61% | 15.66% | 5.03% | 1.83% | 1.11% |
| Operating Income | -15.23% | -31.72% | 7.11% | 59.81% | 93.27% |
| Income Before Tax | -7.07% | -23.60% | 24.05% | 87.04% | 125.60% |
| Income Tax Expenses | 157.51% | 142.75% | 142.12% | 141.55% | -4,444.13% |
| Earnings from Continuing Operations | -52.44% | -63.19% | -49.06% | -37.72% | 230.43% |
| Earnings from Discontinued Operations | -100.00% | -89.59% | 103.70% | 104.57% | 122.89% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.85% | -63.81% | -44.56% | -27.15% | 1,939.61% |
| EBIT | -15.23% | -31.72% | 7.11% | 59.81% | 93.27% |
| EBITDA | 1.64% | -19.61% | 16.36% | 61.20% | 85.12% |
| EPS Basic | -56.24% | -65.59% | -46.54% | -25.83% | 2,871.49% |
| Normalized Basic EPS | -14.42% | -31.56% | 2.24% | 54.52% | 90.48% |
| EPS Diluted | -54.89% | -65.06% | -44.86% | -23.25% | 4,401.45% |
| Normalized Diluted EPS | -9.96% | -24.81% | 20.70% | 95.35% | 110.31% |
| Average Basic Shares Outstanding | 5.36% | 11.26% | 18.20% | 26.13% | 21.89% |
| Average Diluted Shares Outstanding | 0.43% | -0.03% | 0.24% | 6.69% | 13.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |